X.T.L. Biopharmaceuticals Overview

X.T.L. Biopharmaceuticals Gross Profit

Gross Profit analysis for XTLB.

Quarterly Gross Profit

$-43000.00

As of Dec 31, 2024

Annual Gross Profit (TTM)

$119000.00

Trailing 12 months ending Dec 31, 2024

Average Gross Profit (Comparison Companies)

Gross Profit History

Gross Profit Comparison

Annual Gross Profit Growth Rate (%)

Annual Gross Profit Growth (Absolute)

Jump to metric

Total Revenue Cost of Revenue Gross Profit Research & Development Selling, General & Admin Operating Income Other Income Expense Net EBIT Income Tax Net Income Profit Margin